Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMR Vaccination in Pediatric Heart Transplantation Patients
NCT07195032Phase 4Recruiting
- Sponsor
- Children's Mercy Kansas City
- Start
- Sep 2025
- Primary completion
- Sep 2027
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of M-M-R II in measles, mumps, rubella, sponsored by Children's Mercy Kansas City. Started Sep 2025; status: recruiting.
02
Drugs
M-M-R II
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NCT07195032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07195032.